OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Respiratory and Critical Care Medicine is 67. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)

Article	Citations
Very Late Antigen-4: A Novel Receptor for Club Cell Secretory Protein 16 to Control Inflammation	1350
Neuroendocrine Cell Hyperplasia of Infancy (NEHI)/Hiperplasia de Celulas Neuroendocrina de la Infancia (NEHI)	276
Rare Case of Isolated Systemic Arterial Supply to Upper Lobe of Left Lung	263
Electromagnetic Navigation Bronchoscopy and Transthoracic Sampling of Peripheral Pulmonary Nodules: One Step Back, One Leap Forward for the Evaluation of Technology Targeting the Lung Periphery	235
Waxing and Waning Cysts and Nodules	215
Dyspnea in the ICU: It Is Difficult to See What Patients Feel	194
Stop the Asthma Treatment Elevator, We Need to Get Off!	192
COPD Detection: Hurdles and Struggles	188
Nasal High Flow to Modulate Dyspnea in Orally Intubated Weanable Patients	176
Be the Change: Advancing Lung Health and Closing the Global Healthcare Gap	172
The Exposome Applied: A Step toward Defining the Totality of Environmental Exposures in Asthma	160
Differences in Patient Outcomes across the Pulmonary Fibrosis Foundation Care Center Network	158
Asthma and COVID-19: Preconceptions about Predisposition	153
Beyond Septic Shock: Who Else Requires Immediate Antibiotics?	151
Nontraumatic Pneumocephalus after Noninvasive Ventilation	150
Peri-intubation Cardiovascular Collapse in Patients Who Are Critically Ill: Insights from the INTUBE Study	144
Airway Androgen Receptor Expression: Regulator of Sex Differences in Asthma?	136
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward	126
Elexacaftor/Tezacaftor/Ivacaftor Improved Clinical Outcomes in a Patient with N1303K-CFTR Based on In Vitro Experimental Evidence	125
Reply to Jha: Understanding the Pathophysiological and Clinical Changes in Lung Injury Models	125
Large Vessel Vasculitis in a Young Woman with EIF2AK4-associated Pulmonary Capillary Hemangiomatosis/Pulmonary Veno-Occlusive Disease	124
Reply to Jimenez and Hyzy and to Le Stang and Dres	122
Science-based Policy Recommendations for Fine Particulate Matter in the United States	118
Genetically Identifying the “Thromboembolic” in Chronic Thromboembolic Pulmonary Hypertension	115
Deep Learning–based Segmentation of Computed Tomography Scans Predicts Disease Progression and Mortality in Idiopathic Pulmonary Fibrosis	115

Diagnosis and Treatment of Pulmonary Hypertension	113
Tracheal Lobular Capillary Hemangioma	108
August 15 Highlight	108
Specific Respiratory System Compliance in COVID-19 and Non–COVID-19 Acute Respiratory Distress Syndrome	106
Reply to He et al.	105
Concerning the Growth Failure during Lung Function Development: Beyond the Evaluation	105
April 15 Highlight	101
Reply to Jha	99
Identification of Large Airway Collapse with Symptoms Using Dynamic Chest Radiography	98
Remodeling Phenotypes Take Center Stage in the Prediction of Preschool Wheeze Attacks	97
Enhanced Postbronchoscopic Lung Volume Reduction Pneumothorax Detection with Digital Tomosynthesis	93
2022-2023 Journal Award Winners	92
Prognosis of Patients with Chronic Obstructive Pulmonary Disease Not Eligible for Major Clinical Trials	90
Equitably Allocating Resources during Crises: Racial Differences in Mortality Prediction Models	90
Research Needs for Inpatient Management of Severe Alcohol Withdrawal Syndrome: An Official American Thoracic Society Research Statement	86
Reverse Triggering during Controlled Ventilation: From Physiology to Clinical Management	86
Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment?	86
Extracellular Vesicles as Therapy for Congenital Diaphragmatic Hernia–associated Pulmonary Hypoplasia: Extra! Extra! Read All About Autophagy!	81
No One Left Behind: Access to Prevention and Treatment for All: Message on World Lung Day from M. Patricia Rivera, M.D. President of the American Thoracic Society	80
Pulmonary Tumor Thrombotic Microangiopathy Appearance on Dual-Energy Computed Tomography	80
Retraction: Isoniazid and Rifapentine Treatment Eradicates Persistent Mycobacterium tuberculosis in Macaques	80
Lessons from the North: CanCOLD, Exercise, and Chronic Obstructive Pulmonary Disease	80
Retraction: Altered Antibiotic Pharmacokinetics during Extracorporeal Membrane Oxygenation: Cause for Renal Function?	79
Reply to Chung et al. and to Rogliani and Calzetta	79
Reply to Santos et al.: Open Up the Lung and Keep the Lung Vessels Open	78
Endovascular Forceps Biopsy of Pulmonary Artery Intimal Sarcoma: A Safer Approach	78
Disconcerting and Counterintuitive Findings from a Trial of Exercise in Cystic Fibrosis: Can Exercise Make Our Patients Worse?	77
Reply to Tiruvoipati et al.: VENT-AVOID Trial: Avoiding Acute Hypercapnic Respiratory Failure!	76
Lung Function as a Biomarker of Health: An Old Concept Rediscovered	75
Live-attenuated Respiratory Syncytial Virus Vaccines: Time for the Next Step	74
Systemic Air Embolism and Mediastinal Emphysema after Pneumonia	74
Cleaving the Acute Respiratory Distress Syndrome into Treatable Traits: A Role for Caspase 1?	74
Stress Is in the Air: Ambient Reactive Oxygen Species and COVID-19	73
Pneumothorax: Challenging the Paradigm of Persistent Air Leak, but Where Is the Leak?	72
Low-Dose Anticoagulation to Prevent Intracranial Hemorrhage in COVID-19 Patients under Extracorporeal Membrane Oxygenation Support	72
Reply to Wendel-Garcia et al.: Low-Dose Anticoagulation to Prevent Intracranial Hemorrhage in COVID-19 Patients under Extracorporeal Membrane Oxygenation Support	72
Development of a Mask for Bronchoscopy to Prevent Infection during the COVID-19 Pandemic: Image Evaluation	71
Dynamic Metabolic Risk Profiling of World Trade Center Lung Disease: A Longitudinal Cohort Study	69
Scrutinizing the Mechanisms of West Non–Zone 3 Conditions during Tidal Ventilation	69
The Long-Term Respiratory Perils of War	69
A Further Step Toward Meaningful Trial Outcomes for Patients with Pulmonary Arterial Hypertension: Minimal Important Difference in 6-minute-walk Distance	67
Managing Your Asthma: Avoiding Irritants	67